Therapeutic Asset Ratings
200 results matching 1 filter
129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
PARTHENOLIDE (CONSTITUENT OF FEVERFEW)
Alzheimer Disease
Massachusetts General Hospital
P2
CCC
(48)
Prevnar
Multiple Myeloma
Massachusetts General Hospital
P2
CCC
(48)
tenofovir
Multiple Sclerosis
Massachusetts General Hospital
P2
CCC
(48)
Tocilizumab
Major Depressive Disorder
Massachusetts General Hospital
P2
CCC
(48)
Pemigatinib
Cholangiocarcinoma
Massachusetts General Hospital
P1/2
CCC
(48)
Pembrolizumab
Smoldering Multiple Myeloma
Massachusetts General Hospital
P1
CC
(46)
ABATACEPT RECOMBINANT
Mild Cognitive Impairment
Massachusetts General Hospital
P1/2
CC
(46)
Baricitinib
Amyotrophic Lateral Sclerosis
Massachusetts General Hospital
P1/2
CC
(46)
Baricitinib
Cognitive Disorder
Massachusetts General Hospital
P1/2
CC
(46)
Cyclophosphamide
Amyotrophic Lateral Sclerosis
Massachusetts General Hospital
P1/2
CC
(46)
Polyiclc
Smoldering Multiple Myeloma
Massachusetts General Hospital
P1
CC
(44)
Pvx-410
Smoldering Plasma Cell Myeloma
Massachusetts General Hospital
P1
CC
(44)
ABATACEPT RECOMBINANT
Alzheimer Disease
Massachusetts General Hospital
P1/2
CC
(44)
Baricitinib
Alzheimer Disease
Massachusetts General Hospital
P1/2
CC
(44)
Vedolizumab
Amyotrophic Lateral Sclerosis
Massachusetts General Hospital
P1/2
CC
(44)
Vedolizumab
Mild Cognitive Impairment
Massachusetts General Hospital
P1/2
CC
(44)
Atezolizumab
Smoldering Plasma Cell Myeloma
Massachusetts General Hospital
P1
CC
(43)
Inqovi
T-Cell Acute Lymphoblastic Leukemia
Massachusetts General Hospital
P1
CC
(43)
Methylphenidate
Brain Hypoxia - Ischemia
Massachusetts General Hospital
P1
CC
(43)
Methylphenidate
Coma
Massachusetts General Hospital
P1
CC
(43)
Mezigdomide
KMT2A-rearranged
Massachusetts General Hospital
P1
CC
(43)
Mezigdomide
Acute Myeloid Leukemia With Mutated NPM1
Massachusetts General Hospital
P1
CC
(43)
Niraparib
Residual Disease
Massachusetts General Hospital
P1
CC
(43)
Pemigatinib
Unresectable Solid Tumor
Massachusetts General Hospital
P1
CC
(43)
Tirzepatide
Colorectal Adenoma
Massachusetts General Hospital
P1
CC
(43)
Showing 126 to 150 of 200 assets
Previous
Page 6 of 8
Next